Literature DB >> 11155143

Twenty-four hour ambulatory blood pressure in a population of elderly men.

K Björklund1, L Lind, H Lithell.   

Abstract

OBJECTIVES: The principal aim was to study ambulatory and office blood pressure in a population of elderly men. We also wanted to describe the prevalence of hypertension and investigate the blood pressure control in treated elderly hypertensives.
DESIGN: A cross-sectional study of a population of elderly men, conducted between 1991 and 1995.
SUBJECTS: Seventy-year-old men (n = 1060), participants of a cohort study that began in 1970. MAIN OUTCOME MEASURES: Office and 24 h ambulatory blood pressure.
RESULTS: Average 24 h blood pressure in the population was 133 +/- 16/75 +/- 8 mmHg, and daytime blood pressure 140 +/- 16/80 +/- 9 mmHg. Corresponding values in untreated subjects (n = 685) were 131 +/- 16/74 +/- 7 and 139 +/- 16/79 +/- 8, respectively. An office recording of 140/90 mmHg corresponded to an ambulatory pressure of 130/78 (24 h) and 137/83 mmHg (daytime) in untreated subjects. In subjects identified as normotensives according to office blood pressure (n = 270), the 95th percentiles of average 24 h and daytime blood pressures were 142/80 and 153/85 mmHg, respectively. The prevalence of hypertension, defined as office blood pressure greater than or = 140/90 mmHg, was 66%. Despite treatment, treated hypertensives (n = 285) showed higher office (157/89 vs. 127/76 mmHg) and 24 h ambulatory (138/78 vs. 122/71 mmHg) pressures than normotensives (P < 0.05). Fourteen per cent of the treated hypertensives had an office blood pressure < 140/90 mmHg.
CONCLUSIONS: Our results provide a basis for 24 h ambulatory blood pressure reference values in elderly men. The study confirms previous findings of a high prevalence of hypertension at older age. It also indicates that blood pressure is inadequately controlled in elderly treated hypertensives.

Entities:  

Mesh:

Year:  2000        PMID: 11155143     DOI: 10.1046/j.1365-2796.2000.00760.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  6 in total

1.  Age and the difference between awake ambulatory blood pressure and office blood pressure: a meta-analysis.

Authors:  Joji Ishikawa; Yukiko Ishikawa; Donald Edmondson; Thomas G Pickering; Joseph E Schwartz
Journal:  Blood Press Monit       Date:  2011-08       Impact factor: 1.444

2.  Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study.

Authors:  Geoffrey A Head; Anastasia S Mihailidou; Karen A Duggan; Lawrence J Beilin; Narelle Berry; Mark A Brown; Alex J Bune; Diane Cowley; John P Chalmers; Peter R C Howe; Jonathan Hodgson; John Ludbrook; Arduino A Mangoni; Barry P McGrath; Mark R Nelson; James E Sharman; Michael Stowasser
Journal:  BMJ       Date:  2010-04-14

3.  24-Hour ambulatory blood pressure associates inversely with prostaglandin F(2α), interleukin-6 and F(2)-isoprostane formation in a Swedish population of older men.

Authors:  Johanna Helmersson-Karlqvist; Kristina Björklund-Bodegård; Anders Larsson; Samar Basu
Journal:  Int J Clin Exp Med       Date:  2012-04-06

Review 4.  Diagnostic thresholds for ambulatory blood pressure moving lower: a review based on a meta-analysis-clinical implications.

Authors:  Tine W Hansen; Masahiro Kikuya; Lutgarde Thijs; Yan Li; José Boggia; Kristina Björklund-Bodegârd; Christian Torp-Pedersen; Jørgen Jeppesen; Hans Ibsen; Jan A Staessen
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-05       Impact factor: 3.738

Review 5.  Predictors of the Home-Clinic Blood Pressure Difference: A Systematic Review and Meta-Analysis.

Authors:  James P Sheppard; Ben Fletcher; Paramjit Gill; Una Martin; Nia Roberts; Richard J McManus
Journal:  Am J Hypertens       Date:  2015-09-22       Impact factor: 2.689

Review 6.  Sources of inaccuracy in the measurement of adult patients' resting blood pressure in clinical settings: a systematic review.

Authors:  Noa Kallioinen; Andrew Hill; Mark S Horswill; Helen E Ward; Marcus O Watson
Journal:  J Hypertens       Date:  2017-03       Impact factor: 4.844

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.